Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04274465 · ClinicalTrials.gov registry record
Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 145
- Enrollment target
NCT04274465 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 145 participants.
The verdict
NCT04274465 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 145 participants
- Enrollment target
Study Summary
The purpose of this study is to see if circulating HPV DNA (cHPVDNA) can be used as a noninvasive biomarker for cervical intraepithelial neoplasia (CIN) 2-3 in hopes of reducing procedures and costs for patients, as well as personalize their treatment plan.
Interventions
- DIAGNOSTIC_TEST digital PCR (dPCR) assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2020-02-26 |
| Est. Completion | 2024-07-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04274465
The ClinicalTrials.gov registry entry for NCT04274465 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which digital PCR (dPCR) assay is the first listed.
NCT04274465 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04274465 about?
NCT04274465 is a clinical study titled "Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia". The purpose of this study is to see if circulating HPV DNA (cHPVDNA) can be used as a noninvasive biomarker for cervical intraepithelial neoplasia (CIN) 2-3 in hopes of reducing procedures and costs for patients, as well as personalize their treatment plan.
What is the current status of trial NCT04274465?
This trial is currently completed. The enrollment target is 145 participants. The study started on 2020-02-26. Estimated completion is 2024-07-15.
What interventions are being tested in trial NCT04274465?
The interventions under investigation include: digital PCR (dPCR) assay (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04274465?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.